Comparable stake leader
RTW INVESTMENTS, LP
SEC ownership of CG Oncology, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001991792.
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- CGON on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
RTW INVESTMENTS, LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
RTW INVESTMENTS, LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001991792
- Issuer location
- Dallas, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of CG Oncology, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 9.7%
13D/G row: RTW INVESTMENTS, LP
Showing 1-8 of 50 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 9.7%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
9.7%
Decheng Capital Global Life Scien...
8.4%
T. Rowe Price Investment Manageme...
8%
BlackRock, Inc.
6.8%
WELLINGTON MANAGEMENT GROUP LLP
6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
9.7%
from 13D/G
|
$604,961,620
8,514,590 shares
|
— | 30 Jun 2026 |
| Decheng Capital Global Life Sciences Fund IV, L.P. |
13D/G
3/4/5
Xiangmin Cui · 10%+ Owner
|
8.4%
|
$178,215,582
6,371,669 shares
|
$0 | 31 Dec 2024 |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
Company
|
8%
from 13D/G
|
$470,131,000
6,616,899 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.8%
from 13D/G
|
$444,509,264
6,256,288 shares
|
— | 30 Jun 2026 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
Company
|
6%
from 13D/G
|
$378,323,559
5,324,751 shares
|
— | 30 Jun 2026 |
| Longitude Capital Partners IV, LLC |
13D/G
Patrick G. Enright
|
6%
|
$121,032,477
4,662,268 shares
|
$0 | 11 Sep 2025 |
| Unique Diamond Investments Ltd |
13D/G
SONG, Hong Fang
|
5.5%
|
$117,791,208
4,211,341 shares
|
$0 | 31 Dec 2024 |
| FMR LLC |
13F
13D/G
Company
|
5.1%
from 13D/G
|
$295,674,077
4,161,493 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$19,038,807.
Buys
$24,814,454
Insiders: 1
Sells
$5,775,647
Insiders: 2
Net
+$19,038,807
Shares: +276,589
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 371,085
Shares: 94,496
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 27,165 | $0 | $2,034,931 | -$2,034,931 |
| 3-6 | 371,085 | 28,564 | $24,814,454 | $1,986,532 | +$22,827,922 |
| 6-9 | 0 | 13,109 | $0 | $709,513 | -$709,513 |
| 9-12 | 0 | 25,658 | $0 | $1,044,671 | -$1,044,671 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to CG Oncology, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
Hong Fang Song
Net 12M change
+$19,038,807
Latest report
15 Sep 2026
Recent insider transactions for CG Oncology, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Leonard E. Post | CGON | Common Stock | Sale | -100% | $72,980 | $72.98 | -1,000 | 0 | 15 Sep 2026 | Direct |
| Leonard E. Post | CGON | Common Stock | Options Exercise | 1,000 | 1,000 | 15 Sep 2026 | Direct | |||
| Leonard E. Post | CGON | Director Stock Option (right to buy) | Options Exercise | -0.96% | -1,000 | 103,077 | 15 Sep 2026 | Direct | ||
| Leonard E. Post | CGON | Common Stock | Sale | -100% | $74,540 | $74.54 | -1,000 | 0 | 14 Aug 2026 | Direct |
| Leonard E. Post | CGON | Common Stock | Options Exercise | 1,000 | 1,000 | 14 Aug 2026 | Direct | |||
| Leonard E. Post | CGON | Director Stock Option (right to buy) | Options Exercise | -0.95% | -1,000 | 104,077 | 14 Aug 2026 | Direct | ||
| Leonard E. Post | CGON | Common Stock | Sale | -100% | $71,170 | $71.17 | -1,000 | 0 | 15 Jul 2026 | Direct |
| Leonard E. Post | CGON | Common Stock | Options Exercise | 1,000 | 1,000 | 15 Jul 2026 | Direct | |||
| Leonard E. Post | CGON | Director Stock Option (right to buy) | Options Exercise | -0.94% | -1,000 | 105,077 | 15 Jul 2026 | Direct | ||
| James J. Mulay | CGON | Common Stock | Sale | -100% | $1,816,241 | $75.16 | -24,165 | 0 | 10 Jul 2026 | Direct |
| James J. Mulay | CGON | Common Stock | Options Exercise | 24,165 | 24,165 | 10 Jul 2026 | Direct | |||
| James J. Mulay | CGON | Director Stock Option (right to buy) | Options Exercise | -100% | -24,165 | 0 | 10 Jul 2026 | Direct | ||
| Brian Guan-Chyun Liu | CGON | Common Stock | Purchase | 24.5% | $24,814,454 | $66.87 | 371,085 | 1,886,236 | 25 Jun 2026 | By Seven Fleet Partners LP |
| Leonard E. Post | CGON | Common Stock | Sale | -100% | $350,000 | $70.00 | -5,000 | 0 | 24 Jun 2026 | Direct |
| Leonard E. Post | CGON | Common Stock | Options Exercise | 5,000 | 5,000 | 24 Jun 2026 | Direct | |||
| Leonard E. Post | CGON | Director Stock Option (right to buy) | Options Exercise | -4.5% | -5,000 | 106,077 | 24 Jun 2026 | Direct | ||
| Leonard E. Post | CGON | Common Stock | Sale | -100% | $325,000 | $65.00 | -5,000 | 0 | 22 Jun 2026 | Direct |
| Leonard E. Post | CGON | Common Stock | Options Exercise | 5,000 | 5,000 | 22 Jun 2026 | Direct | |||
| Leonard E. Post | CGON | Director Stock Option (right to buy) | Options Exercise | -4.31% | -5,000 | 111,077 | 22 Jun 2026 | Direct | ||
| James J. Mulay | CGON | Common Stock | Sale | -100% | $118,076 | $60.12 | -1,964 | 0 | 15 Jun 2026 | Direct |
| James J. Mulay | CGON | Common Stock | Options Exercise | 1,964 | 1,310 | 15 Jun 2026 | Direct | |||
| James J. Mulay | CGON | Director Stock Option (right to buy) | Options Exercise | -100% | -1,964 | 0 | 15 Jun 2026 | Direct | ||
| Brian Guan-Chyun Liu | CGON | Director Stock Option (right to buy) | Award | 9,354 | 9,354 | 04 Jun 2026 | Direct | |||
| Victor Edward Tong Jr. | CGON | Director Stock Option (right to buy) | Award | 9,354 | 9,354 | 04 Jun 2026 | Direct | |||
| James J. Mulay | CGON | Director Stock Option (right to buy) | Award | 9,354 | 9,354 | 04 Jun 2026 | Direct | |||
| Leonard E. Post | CGON | Common Stock | Sale | -100% | $54,500 | $54.50 | -1,000 | 0 | 04 Jun 2026 | Direct |
| Leonard E. Post | CGON | Common Stock | Options Exercise | 1,000 | 1,000 | 04 Jun 2026 | Direct | |||
| Leonard E. Post | CGON | Director Stock Option (right to buy) | Award | 9,354 | 9,354 | 04 Jun 2026 | Direct | |||
| Leonard E. Post | CGON | Director Stock Option (right to buy) | Options Exercise | -0.85% | -1,000 | 116,077 | 04 Jun 2026 | Direct | ||
| Christina Rossi | CGON | Director Stock Option (right to buy) | Award | 9,354 | 9,354 | 04 Jun 2026 | Direct | |||
| Susan E. Graf | CGON | Director Stock Option (right to buy) | Award | 9,354 | 9,354 | 04 Jun 2026 | Direct | |||
| James J. Mulay | CGON | Common Stock | Sale | -100% | $1,138,956 | $73.01 | -15,600 | 0 | 17 Apr 2026 | Direct |
| James J. Mulay | CGON | Common Stock | Options Exercise | 15,600 | 15,600 | 17 Apr 2026 | Direct | |||
| James J. Mulay | CGON | Director Stock Option (right to buy) | Options Exercise | -100% | -15,600 | 0 | 17 Apr 2026 | Direct | ||
| Ambaw Bellete | CGON | Employee Stock Option (Right to Buy) | Award | 107,508 | 107,508 | 15 Apr 2026 | Direct | |||
| Vijay Kasturi | CGON | Employee Stock Option (Right to Buy) | Award | 79,216 | 79,216 | 15 Apr 2026 | Direct | |||
| Joshua F. Patterson | CGON | Employee Stock Option (Right to Buy) | Award | 45,266 | 45,266 | 15 Apr 2026 | Direct | |||
| James M. Detore | CGON | Employee Stock Option (Right to Buy) | Award | 90,574 | 90,574 | 15 Apr 2026 | Direct | |||
| Arthur Kuan | CGON | Employee Stock Option (Right to Buy) | Award | 271,600 | 271,600 | 15 Apr 2026 | Direct | |||
| James J. Mulay | CGON | Common Stock | Sale | -100% | $124,714 | $63.50 | -1,964 | 0 | 16 Mar 2026 | Direct |
| James J. Mulay | CGON | Common Stock | Options Exercise | 1,964 | 1,310 | 16 Mar 2026 | Direct | |||
| James J. Mulay | CGON | Director Stock Option (right to buy) | Options Exercise | -75% | -1,964 | 654 | 16 Mar 2026 | Direct | ||
| Arthur Kuan | CGON | Common Stock | Tax liability | -0.92% | -1,847 | 198,916 | 12 Mar 2026 | Direct | ||
| Arthur Kuan | CGON | Common Stock | Options Exercise | 47.5% | 64,612 | 200,763 | 12 Mar 2026 | Direct | ||
| Arthur Kuan | CGON | Employee Stock Option (Right to Buy) | Options Exercise | -100% | -64,612 | 0 | 12 Mar 2026 | Direct | ||
| Arthur Kuan | CGON | Common Stock | Tax liability | -2.07% | -2,871 | 136,151 | 04 Mar 2026 | Direct | ||
| Arthur Kuan | CGON | Common Stock | Options Exercise | 284.6% | 102,871 | 139,022 | 04 Mar 2026 | Direct | ||
| Arthur Kuan | CGON | Employee Stock Option (Right to Buy) | Options Exercise | -61.4% | -102,871 | 64,612 | 04 Mar 2026 | Direct | ||
| James J. Mulay | CGON | Common Stock | Sale | -100% | $584,799 | $52.47 | -11,145 | 0 | 09 Jan 2026 | Direct |
| James J. Mulay | CGON | Common Stock | Options Exercise | 11,145 | 10,491 | 09 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.